logo dark logo light logo
  • 首页
  • 关于我们
    • 背景
    • 投资战略
    • 团队
  • 投资组合
  • 新闻中心
  • 联系我们
  • English
  • 投资者登录
mobile-logo
  • 首页
  • 关于我们
    • 背景
    • 投资战略
    • 团队
  • 投资组合
  • 新闻中心
  • 联系我们
  • English
  • 投资者登录
 

新闻中心

19 9月 2018
by admin
in Uncategorized
Comments
Crescendo Biologics shortlisted for Cambridge Independent Science and Technology Awards 2018
18 9月 2018
by admin
in Uncategorized
Comments
resTORbio Appoints Meredith Manning as Chief Commercial Officer
11 9月 2018
by admin
in Uncategorized
Comments
Crescendo Biologics Strengthens its Management with the Appointment of Dr Pavel Pisa as Chief Medical Officer
06 9月 2018
by admin
in Uncategorized
Comments
Centrexion Therapeutics Announces CNTX-4975 Data Presentation at PAINWeek 2018 National Conference
04 9月 2018
by admin
in Uncategorized
Comments
TEMPEST THERAPEUTICS NAMES DR. GINNA LAPORT CMO – Dr. Alicia Levey promoted to CBO –
15 8月 2018
by admin
in Uncategorized
Comments
Centrexion Therapeutics Appoints Dan Mendelson to its Board of Directors
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24

中国上海市浦东新区张江高科技园区金科路4560号金创大厦3号楼8楼,201210
电话: +86 21 6163 2598  |  传真: +86 21 6163 2570  |  邮件: info@quancapital.com

© Quan Capital. All rights reserved. Credit: Website Design